Literature DB >> 28241917

No Indication for Routine Administration.

Frank P Meyer.   

Abstract

Year:  2017        PMID： 28241917      PMCID： PMC5331478          DOI： 10.3238/arztebl.2017.0070a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  3 in total

1.  Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Authors:  Christopher P Cannon; Michael A Blazing; Robert P Giugliano; Amy McCagg; Jennifer A White; Pierre Theroux; Harald Darius; Basil S Lewis; Ton Oude Ophuis; J Wouter Jukema; Gaetano M De Ferrari; Witold Ruzyllo; Paul De Lucca; KyungAh Im; Erin A Bohula; Craig Reist; Stephen D Wiviott; Andrew M Tershakovec; Thomas A Musliner; Eugene Braunwald; Robert M Califf
Journal:  N Engl J Med       Date:  2015-06-03       Impact factor: 91.245

2.  Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.

Authors:  Michael A Blazing; Robert P Giugliano; Christopher P Cannon; Thomas A Musliner; Andrew M Tershakovec; Jennifer A White; Craig Reist; Amy McCagg; Eugene Braunwald; Robert M Califf
Journal:  Am Heart J       Date:  2014-05-15       Impact factor: 4.749

3.  Ezetimibe-Statin Combination Therapy.

Authors:  Barbara Nußbaumer; Anna Glechner; Angela Kaminski-Hartenthaler; Peter Mahlknecht; Gerald Gartlehner
Journal:  Dtsch Arztebl Int       Date:  2016-07-01       Impact factor: 5.594
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.